Fredrik Frejd

Fredrik Frejd

Company: Affibody

Job title: Chief Scientific Officer


A Theranostic Approach to HER2 Radio-ADC Precision Medicine Using Affibody Scaffold Technology 2:00 pm

• HER2-imaging is an attractive tool for characterization of tumor uptake • High contrast tumor targeting ability demonstrated in patients with metastatic breast cancer • Lack of tumor uptake in HER2 IHC+ tumor predicted lack of response to conventional HER2 treatment • Imaging scaffold has been engineered to allow for molecular radiotherapy • Preclinical molecular…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.